Search Results - "Dragojevic, Sonja"
-
1
Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery
Published in International journal of molecular sciences (19-02-2022)“…Although doxorubicin (dox), an anthracycline antibiotic, is widely used and effective in treating cancer, its treatment efficiency is limited by low blood…”
Get full text
Journal Article -
2
Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy
Published in Molecules (Basel, Switzerland) (04-12-2015)“…The majority of anticancer drugs have poor aqueous solubility, produce adverse effects in healthy tissue, and thus impose major limitations on both clinical…”
Get full text
Journal Article -
3
Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives
Published in Frontiers in oncology (17-12-2018)“…Glioblastoma, the most common, aggressive brain tumor, ranks among the least curable cancers-owing to its strong tendency for intracranial dissemination, high…”
Get full text
Journal Article -
4
Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma
Published in Molecules (Basel, Switzerland) (06-09-2019)“…To increase treatment efficiency for glioblastoma, we have developed a system to selectively deliver chemotherapeutic doxorubicin (Dox) to Glioblastoma (GBM)…”
Get full text
Journal Article -
5
Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity
Published in Molecules (Basel, Switzerland) (24-05-2022)“…The anticancer agent doxorubicin(dox) has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite doxorubicin's…”
Get full text
Journal Article -
6
Elastin-like Polypeptide Hydrogels for Tunable, Sustained Local Chemotherapy in Malignant Glioma
Published in Pharmaceutics (28-09-2022)“…Glioblastoma (GBM) is a primary brain tumor that carries a dismal prognosis, which is primarily attributed to tumor recurrence after surgery and resistance to…”
Get full text
Journal Article -
7
Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines
Published in Macromolecular bioscience (01-10-2020)“…The application of rationally designed therapeutic peptides (TP) may improve outcomes in cancer treatment. These peptides hold the potential to directly target…”
Get full text
Journal Article -
8
Abstract 3708: Targeted delivery of doxorubicin to glioblastomas by thermally sensitive polypeptides
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Glioblastoma (GBM) ranks among the most common, aggressive, and least curable cancers due to a strong tendency for intracranial dissemination, high…”
Get full text
Journal Article -
9
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases
Published in The Journal of pharmacology and experimental therapeutics (01-06-2022)“…Cytotoxic effects of chemotherapy and radiation therapy (RT) used for the treatment of brain metastases results from DNA damage within cancer cells. Cells rely…”
Get full text
Journal Article -
10
Abstract 3106: Targeted delivery via Elastin Like Polypeptide: Biodistribution of a doxorubicin derivative in MDA-MB231 human breast cancer xenografts in mice
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract The anticancer agent doxorubicin has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite…”
Get full text
Journal Article -
11
Abstract 2168: Optimizing doxorubicin derivatives delivery using temperature sensitive biopolymers in multidrug resistant breast cancer cells
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract The anticancer agent doxorubicin is an anthracycline compound that shows high potency in treating cancer, and it is one of the most widely used…”
Get full text
Journal Article -
12
Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma
Published in The Journal of pharmacology and experimental therapeutics (01-12-2021)“…The effective treatment of brain tumors is a considerable challenge in part because of the presence of the blood-brain barrier (BBB) that limits drug delivery…”
Get full text
Journal Article -
13
Elastin-like Polypeptide for Targeted Delivery of Doxorubicin in the Treatment of Brain and Breast Cancers
Published 01-01-2019“…Cancer represents a diverse group of diseases that can affect almost all organs and body systems. The traditional treatment for cancer is based on a multimodal…”
Get full text
Dissertation -
14
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts
Published in Molecular cancer therapeutics (02-05-2024)“…Radioresistance of melanoma brain metastases limits the clinical utility of conventionally fractionated brain radiation in this disease, and strategies to…”
Get more information
Journal Article -
15
Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers
Published in International journal of radiation oncology, biology, physics (01-12-2021)“…Genotoxic damage induced by radiation triggers a highly coordinated DNA damage response, and molecular inhibitors of key nodes within this complex response…”
Get full text
Journal Article -
16
EXTH-01. INHIBITION OF DNA-PKcs BY M3814 POTENTIATES EFFICACY OF IONIZING RADIATION IN PATIENT-DERIVED XENOGRAFTS OF MELANOMA BRAIN METASTASES
Published in Neuro-oncology (Charlottesville, Va.) (09-11-2020)“…Abstract Radio-resistance mechanisms limit the benefit of radiation therapy (RT) for melanoma brain metastases. A key pathway for radiation-induced DNA…”
Get full text
Journal Article -
17
Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
Published in Neuro-oncology advances (01-01-2022)“…EGFR targeting antibody-drug conjugates (ADCs) are highly effective against EGFR-amplified tumors, but poor distribution across the blood-brain barrier (BBB)…”
Get full text
Journal Article